Holen Sie sich die Stockscreener-App
125.89
2.25%
2.8293
Schlusskurs vom Vortag:
$123.06
Offen:
$123.86
24-Stunden-Volumen:
280.79K
Relative Volume:
0.41
Marktkapitalisierung:
$7.10B
Einnahmen:
$633.51M
Nettoeinkommen (Verlust:
$-8.10M
KGV:
-406.09
EPS:
-0.31
Netto-Cashflow:
$131.26M
1W Leistung:
-4.77%
1M Leistung:
-13.88%
6M Leistung:
+4.36%
1J Leistung:
-18.72%
1-Tages-Spanne:
$123.37
$127.03
1-Wochen-Bereich:
$118.72
$135.18
52-Wochen-Spanne:
$102.97
$175.77
Repligen Corp Stock (RGEN) Company Profile
Firmenname
Repligen Corp
Sektor
Telefon
(781) 449-9560
Adresse
41 SEYON STREET, WALTHAM, MA
Compare RGEN vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
126.03 | 6.93B | 633.51M | -8.10M | 131.26M | -0.31 |
|
ISRG
Intuitive Surgical Inc
|
504.75 | 176.65B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
171.24 | 49.56B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
83.73 | 40.50B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
258.47 | 37.63B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
43.31 | 36.02B | 28.43B | 1.16B | 1.26B | 1.4457 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-01 | Eingeleitet | HSBC Securities | Buy |
| 2025-09-22 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-07-22 | Fortgesetzt | Stephens | Overweight |
| 2025-06-24 | Eingeleitet | Barclays | Overweight |
| 2025-04-29 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-03-18 | Eingeleitet | Evercore ISI | In-line |
| 2025-02-10 | Eingeleitet | TD Cowen | Buy |
| 2024-12-17 | Eingeleitet | Canaccord Genuity | Hold |
| 2024-11-14 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-26 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-06-18 | Eingeleitet | Guggenheim | Neutral |
| 2023-12-04 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-07-20 | Eingeleitet | Wells Fargo | Overweight |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-03-28 | Eingeleitet | The Benchmark Company | Buy |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-07-20 | Eingeleitet | UBS | Buy |
| 2021-10-14 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-08-24 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-30 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-07 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-23 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-11-01 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-15 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-28 | Bestätigt | First Analysis Sec | Outperform |
| 2019-08-23 | Fortgesetzt | Stephens | Overweight |
| 2019-07-22 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2018-12-17 | Hochstufung | CL King | Neutral → Buy |
| 2018-11-12 | Herabstufung | CL King | Buy → Neutral |
| 2018-09-26 | Eingeleitet | H.C. Wainwright | Neutral |
| 2017-12-08 | Eingeleitet | Citigroup | Buy |
| 2017-12-05 | Eingeleitet | JP Morgan | Overweight |
| 2017-11-13 | Eingeleitet | CL King | Buy |
| 2017-10-02 | Hochstufung | First Analysis Sec | Equal-Weight → Overweight |
| 2017-07-21 | Eingeleitet | William Blair | Outperform |
| 2017-02-13 | Hochstufung | Piper Jaffray | Neutral → Overweight |
Alle ansehen
Repligen Corp Aktie (RGEN) Neueste Nachrichten
Repligen Corporation $RGEN Shares Sold by TD Asset Management Inc - MarketBeat
NZS Capital LLC Has $26.30 Million Stake in Repligen Corporation $RGEN - MarketBeat
Repligen (RGEN) COO uses 3,911 shares to cover tax withholding - Stock Titan
Repligen (RGEN) CEO reports tax-withholding share dispositions in Form 4 - Stock Titan
Repligen (RGEN) director uses 9,897 shares to cover RSU taxes - Stock Titan
Repligen (RGEN) CFO stock withheld to cover RSU tax obligations - Stock Titan
Repligen (RGEN) SVP uses company shares to cover RSU taxes - Stock Titan
Repligen (RGEN) CPO has shares withheld to cover RSU tax bill - Stock Titan
Repligen Corporation (RGEN) Investor Outlook: Exploring a 44.7% Potential Upside in the Bioprocessing Sector - DirectorsTalk Interviews
Repligen Corporation $RGEN Position Boosted by Royce & Associates LP - MarketBeat
3 Reasons to Avoid RGEN and 1 Stock to Buy Instead - Finviz
Artisan Partners Limited Partnership Has $28.44 Million Stock Holdings in Repligen Corporation $RGEN - MarketBeat
Primecap Management Co. CA Has $24.98 Million Stock Position in Repligen Corporation $RGEN - MarketBeat
Repligen (NASDAQ:RGEN) Downgraded to Hold Rating by Wall Street Zen - MarketBeat
Privia Health, Repligen, and RadNet Shares Plummet, What You Need To Know - Yahoo Finance
Repligen Corp (RGEN) Shares Down 3.09% on Feb 27 - GuruFocus
Oversold Conditions For Repligen (RGEN) - Nasdaq
Decoding Repligen Corp (RGEN): A Strategic SWOT Insight - GuruFocus
Repligen (NASDAQ: RGEN) maps 2025 bioprocessing market, debt and control risks - Stock Titan
A Glimpse Into The Expert Outlook On Repligen Through 6 Analysts - Benzinga
Repligen Offers Differentiated Solutions as a Leading Bioprocessing Supplier - Morningstar
Barclays Has Lowered Expectations for Repligen (NASDAQ:RGEN) Stock Price - MarketBeat
Barclays Adjusts Repligen (RGEN) Target Price Amid Overweight Ra - GuruFocus
Wells Fargo Lowers Price Target for RGEN, Maintains Overweight R - GuruFocus
Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y - Finviz
Repligen (NASDAQ:RGEN) Price Target Lowered to $180.00 at Wells Fargo & Company - MarketBeat
Evercore ISI Group Lowers Price Target for Repligen (RGEN) to $1 - GuruFocus
KeyBanc reiterates Repligen stock rating on product momentum - Investing.com
How The Repligen (RGEN) Narrative Is Shifting With New Targets M&A Plans And Products - Yahoo Finance
Repligen (RGEN) Return To Profitability Tests Bullish Growth Narrative In Q4 2025 Results - simplywall.st
Repligen Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
Repligen Corp (RGEN) Q4 2025 Earnings Call Highlights: Strong Or - GuruFocus
Repligen earnings beat by $0.05, revenue topped estimates By Investing.com - Investing.com South Africa
Repligen Q4 Earnings Call Highlights - Yahoo Finance
Repligen Q4 2025 Earnings Beat Estimates, Provides 2026 OutlookNews and Statistics - IndexBox
Earnings call transcript: Repligen Q4 2025 earnings surpass expectations - Investing.com
Earnings call transcript: Repligen Q4 2025 earnings surpass expectations By Investing.com - Investing.com Canada
Repligen Corp. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo
Repligen (RGEN) Tops Q4 Earnings and Revenue Estimates - Yahoo Finance
Repligen (NASDAQ:RGEN) Updates FY 2026 Earnings Guidance - MarketBeat
Repligen (RGEN) Beats Q4 Revenue Expectations with Strong Organi - GuruFocus
Repligen Corp (NASDAQ:RGEN) Stock Falls Despite Q4 Earnings Beat as 2026 Guidance Disappoints - ChartMill
Repligen earnings beat by $0.05, revenue topped estimates - Investing.com
Repligen (NASDAQ:RGEN) Exceeds Q4 CY2025 Expectations - Finviz
Repligen: Fourth Quarter Earnings Overview - Bitget
REPLIGEN ($RGEN) Releases Q4 2025 Earnings - Quiver Quantitative
Repligen beats Q4 estimates but guides below consensus for 2026 - Investing.com
Repligen: Q4 Earnings Snapshot - marketscreener.com
Repligen Q4 Earnings Report: What Investors Need to Know - Benzinga
Repligen Corporation Reports Q4 and Full Year 2025 Financial Results - TradingView
Earnings Flash (RGEN) Repligen Corporation Reports Q4 Revenue $197.9M, vs. FactSet Est of $192.9M - marketscreener.com
Finanzdaten der Repligen Corp-Aktie (RGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Repligen Corp-Aktie (RGEN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| MUIR GLENN P | Director |
Dec 16 '25 |
Option Exercise |
26.12 |
3,366 |
87,920 |
36,622 |
1.26%
2.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):